EUVIMEDEUVIMED entdecken
Fallbericht

Saving a hopeless tooth with a four‐wall bone defect: A case report

Takayoshi Nagahara iD, Tomoyuki Iwata iD, Keinoshin Wada iD, Tomoya Ueda iD, Shoko Kono iD, Kazuhisa Ouhara iD, Noriyoshi Mizuno iD

Clinical Advances in Periodontics · 2026

DOI: 10.1002/cap.10329 ↗

Kurz gefasst

Fallbericht in der Zeitschrift Clinical Advances in Periodontics, 2026. Verfasst von Takayoshi Nagahara und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Dental, Nippon Kokan Fukuyama Hospital, Fukuyama, Japan. Hauptthemen laut MEDLINE: Calcium Phosphates, Fibroblast Growth Factor 2, Bone Substitutes, Alveolar Bone Loss. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 28 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Recombinant human fibroblast growth factor‐2 (rhFGF‐2) has been shown to effectively promote the formation of new periodontal tissues, and its efficacy has been demonstrated in clinical settings. Moreover, the clinical and radiographic outcomes in the treatment of periodontal infrabony defects can be improved by using rhFGF‐2 in combination with a bone substitute. Here, we present a case of four‐wall bone defect in a tooth treated by combination regenerative therapy using rhFGF‐2 and beta‐tricalcium phosphate (βo‐TCP).

Methods

A 43‐year‐old male with a four‐wall bone defect in tooth #28 was subjected to combination therapy with rhFGF‐2 and β‐TCP. Periodontal clinical parameters and radiographic images were evaluated at the first visit, after the initial periodontal treatment, and after 4 months and 4 years postoperation.

Results

Although gingival recession and nonvital pulp were observed postoperation, improvements in the periodontal parameters and radiographic outcomes were subsequently recorded.

Conclusion

Periodontal regenerative therapy with a combination of rhFGF‐2 and β‐TCP showed great potential in the treatment of four‐wall bone defects of teeth. Key points Periodontal regenerative therapy using recombinant human fibroblast growth factor‐2 (rhFGF‐2) and beta‐tricalcium phosphate (β‐TCP) showed immense potential in the treatment of four‐wall bone defect in teeth. In addition to using computed tomography for assessing bone defects and root morphologies, an evaluation of root canal morphology and pulp diagnosis is essential for understanding the internal and external aspects of the defect, which would aid in tooth preservation. Appropriate periodontal and endodontic treatments enabled tooth preservation following apical periodontitis after periodontal regenerative therapy. Plain language summary This case report focuses on a new approach for the treatment of a four‐wall bone defect, a significant dental issue in which the bone around the tooth is damaged, thereby decreasing the stability of the tooth. We treated a 43‐year‐old male patient with a combination of two key components: the growth factor rhFGF‐2, which helps promote the growth of new tissues, and the synthetic bone graft substitute β‐TCP, which acts as a substitute for the missing bone. Over the course of 4 years, we monitored the patient's progress using dental exams and X‐ray photos. Despite some minor side effects, such as gum recession and the loss of tooth vitality, the overall condition of the tooth and surrounding bone showed significant improvement. This combination therapy shows promise in repairing similar bone defects, which would help save teeth that might otherwise be lost.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Calcium PhosphatesFibroblast Growth Factor 2Bone SubstitutesAlveolar Bone LossGuided Tissue Regeneration, PeriodontalHumansMaleAdultRecombinant Proteins

Stichwörter der Autor:innen

beta‐tricalcium phosphatefibroblast growth factor‐2intrabony defectperiodontal regenerationperiodontitis

Substanzen

beta-tricalcium phosphateCalcium PhosphatesFibroblast Growth Factor 2Bone SubstitutesRecombinant Proteins

Autor:innen und Institutionen

  • Department of Dental, Nippon Kokan Fukuyama Hospital, Fukuyama, Japan.
  • Department of Periodontal Medicine, Graduate School of Biomedical and Health Sciences, Hiroshima University, Hiroshima, Japan.
  • Wada Dental Clinic, Fukuyama, Japan.

ORCID-Profile: Takayoshi Nagahara, Tomoyuki Iwata, Keinoshin Wada, Tomoya Ueda, Shoko Kono, Kazuhisa Ouhara, Noriyoshi Mizuno

Zitieren

APA

Nagahara, T., Iwata, T., Wada, K., Ueda, T., Kono, S., Ouhara, K., & Mizuno, N. (2026). Saving a hopeless tooth with a four‐wall bone defect: A case report. Clinical Advances in Periodontics. https://doi.org/10.1002/cap.10329

Vancouver

Nagahara T, Iwata T, Wada K, Ueda T, Kono S, Ouhara K, et al. Saving a hopeless tooth with a four‐wall bone defect: A case report. Clinical Advances in Periodontics. 2026. doi:10.1002/cap.10329

BibTeX
@article{Nagahara2026,
  author = {Nagahara, Takayoshi and Iwata, Tomoyuki and Wada, Keinoshin and Ueda, Tomoya and Kono, Shoko and Ouhara, Kazuhisa and Mizuno, Noriyoshi},
  title = {Saving a hopeless tooth with a four‐wall bone defect: A case report},
  journal = {Clinical Advances in Periodontics},
  year = {2026},
  doi = {10.1002/cap.10329}
}
Kostenlos starten →